Kebede H. Begna - Concepedia

Author

Kebede H. Begna

Mayo Clinic in Arizona ORCID

Also Known As

Begna K, K Begna, K H Begna, K. Begna, K. H. Begna, K.H. Begna, Kebede Begna, Kebede H Begna, Kebede H. Begna

315

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic WinnMed Mayo Clinic in Florida Moffitt Cancer Center

About

Kebede H. Begna is an author at Mayo Clinic in Arizona specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.5K
2	Health Sciences	9	9	365
3	Public Health	3	3	130
4	Allergy	1	1	18
5	Biostatistics	1	1	24

Kebede H. Begna

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Journal of Clinical Oncology	2010	1K
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis Ayalew Tefferi, Terra L. Lasho, Kebede H. Begna, New England Journal of Medicine	2015	317
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis Ayalew Tefferi, Paola Guglielmelli, Maura Nicolosi, Leukemia	2018	284
One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience Ayalew Tefferi, Terra L. Lasho, Thitina Jimma, Mayo Clinic Proceedings Hematological MalignancyMayo Clinic ExperienceHematologyPathologyMedicine	2012	240
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis Animesh Pardanani, Rebecca R. Laborde, Terra L. Lasho, Leukemia	2013	229
Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients Domenica Caramazza, Kebede H. Begna, Naseema Gangat, Leukemia	2010	175
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, Mayo Clinic Proceedings Hematological MalignancyMedicineOutcomes DataHematologyMyeloid Neoplasia	2019	151
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts Ayalew Tefferi, Mythri Mudireddy, Francesco Mannelli, Leukemia	2018	138
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients Erika Morsia, Kristen McCullough, Maansi Joshi, American Journal of Hematology Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2020	133
Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients Ayalew Tefferi, Maura Nicolosi, Mythri Mudireddy, Leukemia	2018	124

Page 1